Mr. Autterson is currently President and Chief Executive Officer of CNS Biosciences, Inc., founded in 2013 by Scott Falci, M.D. CNS is a clinical-stage drug development company focusing on neuropathic pain.
Autterson began his career at First Trust Corporation a subsidiary of Fiserv. Later in 1982, Matthew left and joined a small team to establish a new state-chartered trust company in Colorado as a subsidiary of New York-based financial services company Integrated Resources, Inc. In 1986, he became the president of Resources Trust Company, which was acquired by Broad Inc. in 1989 together with other assets owned by Integrated Resources. The company later became Sun America that was purchased by AIG for $18B in 1998. AIG then sold the company to Fiserv in 2001.
Matthew is a member of the Board of Falci Adaptive Biosystems (FAB). FAB is a nonprofit organization dedicated to helping those with neuromotor disabilities increase their ability to control and interact with their environment.
Mr. Autterson graduated from Michigan State University with a B.A. in Finance in 1979. He attended the University of Denver Graduate Tax Program.
As a leader in Colorado’s business community, FAB represents Mr. Autterson’s current philanthropic interests following many years of leadership roles with the Board of the Denver Zoo, and Denver Zoological Foundation, the Webb-Waring Foundation and as Chairman of the Board of Directors of Denver Hospice. Mr. Autterson is a former officer and member of the Young Presidents Organization and World Presidents Organization.